What HeartBeam, Inc. does.

HeartBeam is a medical technology company focused on transforming cardiac care through the power of personalized insights. Our aim is to deliver innovative, higher resolution ambulatory cardiac monitoring solutions that can be used by patients anywhere to enable the detection and monitoring of cardiac disease outside of a healthcare facility. Our ability to develop higher resolution Electrocardiogram (“ECG”) solutions is achieved through the development of our proprietary and patented technology platform that allows us to collect the heart’s electrical activity from three dimensions and synthesize a 12-Lead (“12L”) ECG from these signals.

We believe our Products (“Products” or “Product”) and services will benefit many stakeholders, including patients, healthcare providers, and healthcare payers, and will also address the rapidly growing field of ambulatory cardiac monitoring. As part of our long-term vision, we believe that we are uniquely positioned to play a central role in high-risk Coronary Artery Disease (“CAD”) monitoring, given positive, proof-of-concept data from the initial feasibility studies that demonstrated comparable performance of the HeartBeam System and the standard 12L ECG in ischemia detection. CAD patients are at increased risk for a heart attack or Myocardial Infarction (“MI”). Additionally, our unique portable form-factor will make high-fidelity insights easily accessible, wherever patients are, compared to a standard 12L ECG, which is typically limited to a healthcare setting.

Revenue and profit, by fiscal year.

More on BEATW.

• HeartBeam, Inc. summary
• HeartBeam, Inc. financial statements
• HeartBeam, Inc. key metrics
• HeartBeam, Inc. health scores and style box
• HeartBeam, Inc. earnings
• HeartBeam, Inc. dividends
• HeartBeam, Inc. valuation
• HeartBeam, Inc. ownership and insiders
• HeartBeam, Inc. peers

Figures from HeartBeam, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.